Ftse Mib
35.297,77
0,49%
DAX
20.367,10
0,52%
S&P 500
5.842,91
0,11%
NASDAQ
19.044,39
-0,23%
Bitcoin
96.913,03
0,42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Magenta Therapeutics Inc (MGTA) Magenta Therapeutics Inc (MGTA) Notizie

MGTA

Magenta Therapeutics (MGTA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MGTA
DataOraFonteTitoloSimboloCompagnia
16/09/202422:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
16/09/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
13/09/202402:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
08/08/202422:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
08/08/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
29/05/202402:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
02/04/202400:34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
28/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202422:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
21/03/202421:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
14/02/202422:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/02/202422:32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTAMagenta Therapeutics Inc
31/01/202418:11Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:MGTAMagenta Therapeutics Inc
04/10/202322:20Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTAMagenta Therapeutics Inc
21/09/202303:50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
14/09/202303:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
31/08/202315:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:MGTAMagenta Therapeutics Inc
17/07/202315:30Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
22/06/202323:25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202322:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202322:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202323:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202322:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202314:43Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202314:00Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202313:00GlobeNewswire Inc.Magenta Therapeutics and Dianthus Therapeutics Announce Merger AgreementNASDAQ:MGTAMagenta Therapeutics Inc
01/05/202314:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:MGTAMagenta Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MGTA

La tua Cronologia

LATK
ANMLUSDT
Animal Concerts Token
COIN
SEOSUSD
Smart Eye Operating System
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network